top of page
The Professional Network for Healthcare Experts
FDA approves Genentech Enspryng as first at-home subcutaneous treatment for thyroid eye disease
The FDA has approved Genentech's Enspryng as the first at-home subcutaneous treatment option for adults with thyroid eye disease.
nuaxia
Oct 202 min read
Roche signs $1.53bn global licensing deal for Simcere's B-cell antibody SIM0660
The agreement gives Roche exclusive global rights to develop, manufacture and commercialise Simcere Zaiming's investigational trispecific antibody SIM0660 outside Greater China.
nuaxia
Sep 22 min read
Lilly agrees acquisition of Merida Biosciences in deal worth up to $2.875bn
Lilly’s planned acquisition of Merida Biosciences adds an antibody-engineering platform designed to selectively remove disease-causing antibodies while preserving normal immune function.
nuaxia
Sep 12 min read
bottom of page